Emory University

Angela Caliendo, MD, PhD, FIDSA

Dr. Caliendo is Professor and Vice Chair of Pathology and Laboratory Medicine, Director of Emory Medical Laboratories, and Medical Director of the Clinical Microbiology and Molecular Diagnostics Laboratories at Emory University Hospital. She is an Associate Professor of Medicine (Infectious Diseases) and Director of Infectious Diseases at Emory University Hospital.

Dr. Caliendo received her MD and PhD (Biochemistry) from Case Western Reserve University School of Medicine. She completed an internship and residency in Internal Medicine at Brigham and Women’s Hospital in Boston, MA, and an Infectious Diseases fellowship at Massachusetts General Hospital, Boston, MA. She served as Assistant Director of the Clinical Microbiology Laboratory at Massachusetts General Hospital, where she directed the Virology and Molecular Diagnostics sections of the lab. She was recruited to Emory University in June 1999 as the Medical Director of Microbiology and Molecular Diagnostics Laboratories and in 2001 was appointed Medical Director of Emory Medical Laboratories and in 2003 Vice Chair of Clinical Pathology.

Dr. Caliendo is an Associate Editor of the Journal of Clinical Virology, the Journal of Molecular Diagnostics, and Clinical Microbiology Reviews and serves on the Editor Board of the Journal of Clinical Microbiology. She was past president of the Association of Molecular Pathology, a member of the CLSI (formerly NCCLS) subcommittee on Molecular Methods for Quantitative Testing in Infectious Diseases, and the Co-chairman of the ACTG working group on CMV quantitative methods, and an ASM Foundation Speaker. Dr. Caliendo is the Co-Director of the Virology Core for the Emory Center for AIDS Research and has extensive experience performing and developing molecular diagnostic tests for the detection and quantitation of infectious diseases including HIV-1, HCV, CMV, Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC), and HIV-1 and HCV genotyping assays. She has developed molecular assays for the detection of a variety of pathogens including Mycoplasma pneumoniae, Chlamydia pneumoniae, HSV, Trichomonas vaginalis, the mecA gene (methicillin resistance in Staphylococcus aureus), and a quantitative EBV assay. Dr. Caliendo also has experience in the design and execution of multi-center clinical studies, she has Chaired working groups that have evaluated various CMV, HCV, and HBV viral load assays and her laboratory provides infrastructure and molecular testing for numerous multi-center clinical studies. Her research interests include evaluation of HIV-1 RNA burden and the development of antiretroviral resistance in the plasma and cervical secretions of seropositive women; and the development of molecular diagnostic tests for various infectious diseases.